Mc Adam, LLC T2 Biosystems, Inc. Transaction History

Mc Adam, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	BUY	$0.46 - $0.94 $17,480 - $35,720	38,000 Added 50.53%	113,201 $58,000
Q3 2021 Oct 05, 2021	BUY	$0.86 - $1.21 $4,880 - $6,866	5,675 Added 8.16%	75,201 $69,000
Q2 2021 Aug 02, 2021	SELL	$1.04 - $1.69 $8,320 - $13,520	-8,000 Reduced 10.32%	69,526 $72,000
Q1 2021 Apr 26, 2021	SELL	$1.32 - $3.79 $2,902 - $8,334	-2,199 Reduced 2.76%	77,526 $126,000
Q4 2020 Jan 12, 2021	BUY	$1.06 - $1.51 $2,029 - $2,891	1,915 Added 2.46%	79,725 $128,000
Q3 2020 Nov 13, 2020	BUY	$1.15 - $2.1 $60,098 - $109,746	52,260 Added 204.54%	77,810 $106,000
Q2 2020 Jul 31, 2020	BUY	$0.48 - $1.67 $12,264 - $42,668	25,550 New	25,550 $32,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.